Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
Frontiers in Cardiovascular Medicine · 07.07.2023 · 10
DOI: 10.3389/fcvm.2023.1175174 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 07.07.2023. Verfasst von Yifei Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Ningxia Medical University, Yinchuan, China. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Inflammation is a risk factor for cardiovascular disease (CVD), and particular inflammatory parameters can be used to predict the incidence of CVD. The aim of this study was to assess the association between fibrinogen (FIB), interleukin-6 (IL-6), C-reactive protein (CRP) and galectin-3 (Gal-3) and the risk of cardiovascular disease using meta-analysis.
Methods
PubMed, Embase, Scopus, and Web of Science databases were searched with the appropriate strategies to identify observational studies relevant to this meta-analysis. A random-effects model was used to combine inflammation factor-associated outcomes and cardiovascular disease outcomes, except in the case of galectin-3, where a fixed-effects model was used because of less heterogeneity. Location, age, type of cardiovascular disease, and sample size factors were used to explore heterogeneity in stratification and metaregression for subgroup analysis. A case-by-case literature exclusion approach was used for sensitivity analysis. The funnel plot and Begg's test were combined to assess publication bias.
Results
Thirty-three papers out of 11,456 were screened for inclusion in the analysis. Four inflammation biomarkers were significantly associated with the development of CVD: FIB (OR: 1.21, 95% CI: 1.15–1.27, P < 0.001; HR: 1.04, 95% CI: 1.00–1.07, P < 0.05), IL-6 (HR: 1.16, 95% CI: 1.10–1.22, P < 0.001), CRP (OR: 1.25, 95% CI: 1.15–1.35, P < 0.001; HR: 1.20, 95% CI: 1.14–1.25, P < 0.001) and Gal-3 (HR: 1.09, 95% CI: 1.05–1.14, P < 0.001). Location factors help explain the source of heterogeneity, and there is publication bias in the Gal-3 related literature.
Conclusion
Taken together, the current research evidence suggests that high levels of fibrinogen, interleukin-6, C-reactive protein and galectin-3 are risk factors for cardiovascular disease and can be used as biomarkers to predict the development of cardiovascular disease to some extent. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO , identifier: CRD42023391844.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health, Ningxia Medical University, Yinchuan, China.
- Key Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, Ningxia, China.
Zitieren
APA
Liu, Y., Guan, S., Xu, H., Zhang, N., Huang, M., & Liu, Z. (2023). Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1175174
Vancouver
Liu Y, Guan S, Xu H, Zhang N, Huang M, Liu Z. Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1175174
BibTeX
@article{Liu2023,
author = {Liu, Yifei and Guan, Suzhen and Xu, Haiming and Zhang, Na and Huang, Min and Liu, Zhihong},
title = {Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fcvm.2023.1175174}
}
EUVIMED